On October 15, 2025, it was reported that the Lilly Endowment Inc. sold 3,658 shares of Eli Lilly & Co. common stock for a total of $3.16 million. The transactions took place on October 10, 2025, according to a Form 4 filing with the Securities and Exchange Commission. Following these sales, the Lilly Endowment still holds a significant position with 94,533,320 shares. While this sale by a major shareholder is noteworthy, it is not a direct announcement from Eli Lilly and Company regarding its business operations. No specific market reaction analysis to this particular transaction on October 15, 2025, was available in the search results.